These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 23527569)

  • 1. Probing the structure of Mycobacterium tuberculosis MbtA: model validation using molecular dynamics simulations and docking studies.
    Maganti L; Open Source Drug Discovery Consortium ; Ghoshal N
    J Biomol Struct Dyn; 2014; 32(2):273-88. PubMed ID: 23527569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance mechanism of PncA in Mycobacterium tuberculosis.
    Rajendran V; Sethumadhavan R
    J Biomol Struct Dyn; 2014; 32(2):209-21. PubMed ID: 23383724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D-QSAR studies and shape based virtual screening for identification of novel hits to inhibit MbtA in Mycobacterium tuberculosis.
    Maganti L; ; Ghoshal N
    J Biomol Struct Dyn; 2015; 33(2):344-64. PubMed ID: 24417439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights on Mycobacterium tuberculosis thiazole synthase--a molecular dynamics/docking approach.
    Rohini K; Srikumar PS
    Appl Biochem Biotechnol; 2013 Mar; 169(6):1790-8. PubMed ID: 23340867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.
    Fakhar Z; Naiker S; Alves CN; Govender T; Maguire GE; Lameira J; Lamichhane G; Kruger HG; Honarparvar B
    J Biomol Struct Dyn; 2016 Nov; 34(11):2399-417. PubMed ID: 26612108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Target-Based and Phenotypic Screening Approaches for the Identification of Anti-Tubercular Agents That Bind to the Mycobacterial Adenylating Enzyme MbtA.
    Ferguson L; Wells G; Bhakta S; Johnson J; Guzman J; Parish T; Prentice RA; Brucoli F
    ChemMedChem; 2019 Oct; 14(19):1735-1741. PubMed ID: 31454170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic Analyses of the Siderophore Biosynthesis Inhibitor Salicyl-AMS and Analogues as MbtA Inhibitors and Antimycobacterial Agents.
    Bythrow GV; Mohandas P; Guney T; Standke LC; Germain GA; Lu X; Ji C; Levendosky K; Chavadi SS; Tan DS; Quadri LEN
    Biochemistry; 2019 Feb; 58(6):833-847. PubMed ID: 30582694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-docking study on InhA inhibitors: a combination of Autodock Vina and PM6-DH2 simulations to retrieve bio-active conformations.
    Stigliani JL; Bernardes-Génisson V; Bernadou J; Pratviel G
    Org Biomol Chem; 2012 Aug; 10(31):6341-9. PubMed ID: 22751934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative three dimensional structure linear interaction energy model of 5'-O-[N-(salicyl)sulfamoyl]adenosine and the aryl acid adenylating enzyme MbtA.
    Labello NP; Bennett EM; Ferguson DM; Aldrich CC
    J Med Chem; 2008 Nov; 51(22):7154-60. PubMed ID: 18959400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
    Saxena S; Abdullah M; Sriram D; Guruprasad L
    J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC of Leptospira spp.: homology modeling, docking, and molecular dynamics study.
    Pradhan D; Priyadarshini V; Munikumar M; Swargam S; Umamaheswari A; Bitla A
    J Biomol Struct Dyn; 2014; 32(2):171-85. PubMed ID: 23383626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the drug resistance induced by the BaDHPS mutations: molecular dynamic simulations and MM/GBSA studies.
    Chu WT; Zhang JL; Zheng QC; Chen L; Xue Q; Zhang HX
    J Biomol Struct Dyn; 2013 Oct; 31(10):1127-36. PubMed ID: 23030549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resisting resistant Mycobacterium tuberculosis naturally: mechanistic insights into the inhibition of the parasite's sole signal peptidase Leader peptidase B.
    Dhiman H; Dhanjal JK; Sharma S; Chacko S; Grover S; Grover A
    Biochem Biophys Res Commun; 2013 Apr; 433(4):552-7. PubMed ID: 23510997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5'-O-[(N-acyl)sulfamoyl]adenosines as antitubercular agents that inhibit MbtA: an adenylation enzyme required for siderophore biosynthesis of the mycobactins.
    Qiao C; Gupte A; Boshoff HI; Wilson DJ; Bennett EM; Somu RV; Barry CE; Aldrich CC
    J Med Chem; 2007 Nov; 50(24):6080-94. PubMed ID: 17967002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing ligand binding modes of Mycobacterium tuberculosis MurC ligase by molecular modeling, dynamics simulation and docking.
    Anuradha CM; Mulakayala C; Babajan B; Naveen M; Rajasekhar C; Kumar CS
    J Mol Model; 2010 Jan; 16(1):77-85. PubMed ID: 19484275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Andrographolide: A potent antituberculosis compound that targets Aminoglycoside 2'-N-acetyltransferase in Mycobacterium tuberculosis.
    Prabu A; Hassan S; Prabuseenivasan ; Shainaba AS; Hanna LE; Kumar V
    J Mol Graph Model; 2015 Sep; 61():133-40. PubMed ID: 26245695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative modeling and dynamic simulation of UDP-N-acetylmuramoyl-alanine ligase (MurC) from Mycobacterium tuberculosis through virtual screening and toxicity analysis.
    Isa MA
    Life Sci; 2020 Dec; 262():118466. PubMed ID: 32961233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the structural requirements of aminopyrimidine derivatives for good potency against both purified enzyme and whole cells of M. tuberculosis: combination of HQSAR, CoMSIA, and MD simulation studies.
    Punkvang A; Hannongbua S; Saparpakorn P; Pungpo P
    J Biomol Struct Dyn; 2016 May; 34(5):1079-91. PubMed ID: 26156406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of ligand and structure based approaches for identification of novel MbtI inhibitors in Mycobacterium tuberculosis and molecular dynamics simulation studies.
    Maganti L; Grandhi P; Ghoshal N
    J Mol Graph Model; 2016 Nov; 70():14-22. PubMed ID: 27639087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of novel coupled mutations in the katG gene (His276Met, Gln295His and Ser315Thr) in a multidrug-resistant Mycobacterium tuberculosis strain from Chennai, India, and insight into the molecular mechanism of isoniazid resistance using structural bioinformatics approaches.
    Ramasubban G; Therese KL; Vetrivel U; Sivashanmugam M; Rajan P; Sridhar R; Madhavan HN; Meenakshi N
    Int J Antimicrob Agents; 2011 Apr; 37(4):368-72. PubMed ID: 21330112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.